Skip to main content
search

Diplomat

By December 9, 2019Headlines

And the big just keep getting bigger, as OptumRx, the UnitedHealth unit, is buying Diplomat, a specialty pharmacy and infusion vendor, for around $4 a share.

https://www.businesswire.com/news/home/20191209005205/en/Diplomat-OptumRx-Combining-Advance-Access-Specialty-Pharmacy

Tags:

Related Posts

Headlines
February 6, 2024

Cano

Cano Health apparently cannot, as it declares bankruptcy due to too much debt.  Building primary…
Kevin Roche 0
Headlines
January 24, 2024

Turquoise

Turquoise health raises a fresh $30 million in capital for its price transparency platform, as…
Kevin Roche 0
Headlines
January 24, 2024

CAR-T safety

I am co-f0under of a company that manages cell and gene therapy for health plans.…
Kevin Roche 0

Leave a comment

Close Menu